, Volume 19, Issue 2, pp 245-256

DNA vaccines: safety and efficacy issues

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


DNA technology has been harnessed to produce a variety of plasmid-based vaccines designed to prevent viral, bacterial and parasitic infections. The rapid adoption and implementation of this novel vaccine strategy carries with it important safety and efficacy concerns. This review will focus on whether DNA vaccines (1) are likely to induce systemic or organ-specific autoimmune disease, (2) have the potential to induce tolerance rather than immunity, and (3) are as effective in individuals with depressed immune function as they are in healthy adults.